Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Development of a vaccine against feline rabies. Experiment outside containment (clinical trial) for the study of the safety and the efficacy of a subcutaneous administration of a recombinant canarypoxvirus expressing the surface glycoprotein G gene from Rabies virus (vCP65).

Proposed period of release:
01/05/2006 to 31/12/2006

Name of the Institute(s) or Company(ies)
Merial Laboratoires, 17, rue Bourgelat
F-69002 Lyon;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
vCP65 consisting of a recombinant canarypox virus expressing the surface glycoprotein G gene from Rabies virus, under control of the H6 promoter from the vaccinia virus.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
CanarypoxvirusAvipoxvirusCanarypoxvirusstrain of the KANAPOX vaccine

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known